Obiettivo The project aims at validate TSP-1 neutralisation as a potentially useful pharmacological approach in the therapeutic treatment of thrombosis Campo scientifico medical and health sciencesclinical medicineangiologyvascular diseases Programma(i) FP5-LIFE QUALITY - Specific Programme for research, technological development and demonstration on "Quality of life and management of living resources", 1998-2002 Argomento(i) 1.1.1.-7. - Chronic and degenerative diseases, cancer, diabetes, cardivascular diseases and rare diseases Invito a presentare proposte Data not available Meccanismo di finanziamento RGI - Research grants (individual fellowships) Coordinatore KATHOLIEKE UNIVERSITEIT LEUVEN Contributo UE Nessun dato Indirizzo Herestraat 49 Campuse Gasthuisberg 3000 LOUVAIN / LEUVEN Belgio Mostra sulla mappa Costo totale Nessun dato